SCHEMBL4036130

SCHEMBL4036130

COc1ccc(F)c(C(C(=O)NC2CCCCC2)C2(c3ccc(Cl)cc3)Nc3ccccc3N2)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.42
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
CNR1 P21554 2/20 0.38
CNR2 P34972 2/20 0.38
YAP1 P46937 2/20 0.38
TEAD4 Q15561 2/20 0.38
ALDH1A1 P00352 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP1A2 P05177 1/20 0.37
AVPR1A P37288 1/20 0.37
TSHR P16473 2/20 0.37
HRH3 Q9Y5N1 1/20 0.37
CYP2D6 P10635 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4044491 0.88 KMT2A (0.41) NR1H4MEN1KMT2ACNR1CNR2
SCHEMBL4038206 0.86 NPC1 (0.43) NR1H4MEN1KMT2AYAP1TEAD4
SCHEMBL4037444 0.82 NR1H4 (0.48) NR1H4MEN1KMT2ACNR1CNR2
SCHEMBL4045000 0.82 NR1H4 (0.48) NR1H4MEN1KMT2ACNR1CNR2
SCHEMBL4038480 0.82 NR1H4 (0.48) NR1H4MEN1KMT2ACNR1CNR2
SCHEMBL4044209 0.80 HRH3 (0.43) NR1H4CNR1ALDH1A1NPC1RAB9A
SCHEMBL4038040 0.80 TSHR (0.38) MEN1KMT2ACNR1ALDH1A1SMN1; SMN2
SCHEMBL4038946 0.79 OPRL1 (0.41) MEN1KMT2ACNR1CNR2NPC1
SCHEMBL4042732 0.78 NR1H4 (0.44) NR1H4MEN1KMT2AALDH1A1NPC1
SCHEMBL4039101 0.78 NR1H4 (0.44) NR1H4MEN1KMT2AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP claimed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO claimed
EP-3043865-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2016-07-20 EP disclosed
WO-2015036442-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-03-19 WO disclosed
EP-2038259-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F.HOFFMANN-LA ROCHE AG (CH) 2009-03-25 EP disclosed
WO-2008000643-A1 BENZIMIDAZOLE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS FXR AGONISTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME F. HOFFMANN-LA ROCHE AG (CH) 2008-01-03 WO disclosed